The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1496
ISSUE 1496
June 6, 2016
Issue 1496
- Drugs for Multiple Sclerosis
- Pimavanserin (Nuplazid) for Parkinson's Disease Psychosis
- Alternatives to Fluoroquinolones
- In Brief: New Indications for Secukinumab (Cosentyx)
- In Brief: Liposomal Irinotecan (Onivyde) for Pancreatic Cancer (online only)
- In Brief: Trifluridine/Tipiracil (Lonsurf) for Metastatic Colorectal Cancer (online only)
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Drugs for Multiple Sclerosis
June 6, 2016 (Issue: 1496)
Most patients with multiple sclerosis (MS) present
with the relapsing-remitting form of the disease.
Treatment usually includes disease-modifying drugs,
various other drugs for managing symptoms such as
fatigue, depression, and pain, and...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.